SCHEMBL5140157

SCHEMBL5140157

N[C@H]1CCSc2cc(C(=O)Nc3ccnc4[nH]ccc34)c(Cl)cc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.49
JAK1 P23458 1/20 0.49
TYK2 P29597 1/20 0.49
ROCK2 O75116 5/20 0.42
ROCK1 Q13464 3/20 0.42
PRKD3 O94806 2/20 0.42
PRKACA P17612 2/20 0.42
PRKCQ Q04759 2/20 0.42
PRKCD Q05655 2/20 0.42
PKN2 Q16513 2/20 0.42
PRKD2 Q9BZL6 2/20 0.42
PRKCI P41743 2/20 0.42
ACVR1 Q04771 2/20 0.42
AKT1 P31749 2/20 0.42
PLK4 O00444 1/20 0.42
PDPK1 O15530 1/20 0.42
RPS6KA5 O75582 1/20 0.42
PAK4 O96013 1/20 0.42
PRKCG P05129 1/20 0.42
CDK1 P06493 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5140162 1.00 JAK2 (0.49) JAK2JAK1TYK2ROCK2ROCK1
SCHEMBL5956771 0.89 ROCK2 (0.46) JAK2JAK1TYK2ROCK2ROCK1
SCHEMBL5956758 0.89 ROCK2 (0.46) JAK2JAK1TYK2ROCK2ROCK1
SCHEMBL4440947 0.86 PAK1 (0.35) JAK2JAK1TYK2IRAK4GSK3B
SCHEMBL4451544 0.86 PAK1 (0.35) JAK2JAK1TYK2IRAK4GSK3B
SCHEMBL4445996 0.86 PAK1 (0.35) JAK2JAK1TYK2IRAK4GSK3B
Hydrochloric Acid SCHEMBL5956684 0.85 PAK1 (0.35) JAK2JAK1TYK2IRAK4GSK3B
SCHEMBL2855646 0.84 ROCK2 (0.51) JAK2JAK1TYK2ROCK2ROCK1
SCHEMBL2855653 0.84 ROCK2 (0.51) JAK2JAK1TYK2ROCK2ROCK1
SCHEMBL4442282 0.84 ROCK2 (0.51) JAK2JAK1TYK2ROCK2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1270570-B1 AMIDE COMPOUNDS AND USE THEREOF MITSUBISHI PHARMA CORP (JP) 2006-05-31 EP claimed
WO-2008049000-A2 COMBINATION THERAPY FOR PULMONARY ARTERIAL HYPERTENSION UNITED THERAPEUTICS CORPORATION (US) 2008-04-24 WO disclosed